Clinical Trial Update: Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing Exubera with subcutaneous human insulin in children and adolescents with Type 1 diabetes; terminated with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)
• Insulin (insulin)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: TERMINATED | Results posted: 2008-11-03